Background: Both genetic and environmental factors influence, susceptibility to autoimmune disorders including Behcet's disease (BD). FCRL3 (Fc receptor like 3 genes), a novel immunoregulatory gene, has recently been reported as a new promising candidate gene for general autoimmunity. This study was conducted to explore the potential association of FCRL3 polymorphisms with BD.

Methods: This study was conducted from 2010 to 2015 in Tehran University of Medical Sciences, Tehran, Iran. Four single-nucleotide polymorphisms of FCRL3 (rs7528684, rs11264799, rs945635, and rs3761959) were genotyped in 220 patients and 220 healthy controls. Typing of the polymorphisms in this case-control study was carried out using polymerase chain reaction-restriction fragment length polymorphism analysis.

Results: Analysis of the alleles revealed a significantly lower frequency of the A allele at the -169 site (rs7528684) in BD patients compared with that in controls (=0.000, 66.4% versus 82%, χ= 30.23). Moreover, a significant lower frequency of AA genotype and higher frequency of GG genotype was recorded for rs7528684. There was also relationship between posterior uveitis as a clinical sign of disease and polymorphism of allele A at the -169 site (=0.015).

Conclusion: This study revealed a significant difference in both allele and genotype frequency at position -169 of FCRL3 gene between Iranian patients with BD and normal subjects. These data suggest FCRL3 gene polymorphisms might be the autoimmunity risk factor for BD.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635340PMC

Publication Analysis

Top Keywords

polymorphisms fcrl3
8
iranian patients
8
behcet's disease
8
study conducted
8
lower frequency
8
allele -169
8
-169 site
8
frequency genotype
8
fcrl3 gene
8
fcrl3
6

Similar Publications

Background: Multiple sclerosis (MS) represents a multifaceted autoimmune ailment, prompting the development and widespread utilization of numerous therapeutic interventions. However, extant medications for MS have proven inadequate in mitigating relapses and halting disease progression. Innovative drug targets for preventing multiple sclerosis are still required.

View Article and Find Full Text PDF

Genomic variants associated with age at diagnosis of childhood-onset type 1 diabetes.

J Hum Genet

November 2024

Inserm U1169, now at MIRCEN, Commissariat à l'Énergie Atomique, Fontenay-aux-Roses, France.

Article Synopsis
  • - The age at diagnosis of Type 1 diabetes (T1D) is influenced by both the age at which autoimmune damage begins and the speed at which beta cells are destroyed, with genetics playing a key role, particularly in children.
  • - A study of European children diagnosed with T1D from 1980-2008 identified 14 specific SNPs (genetic variants) associated with age at diagnosis, including new associations not found in previous studies.
  • - Many of the identified genetic loci are linked to immune system functions and other autoimmune conditions, indicating that these genes may significantly contribute to the early immune processes leading to beta cell destruction in T1D.
View Article and Find Full Text PDF
Article Synopsis
  • * The research involved 6,768 participants who underwent urine tests, with detailed analysis of over 3.6 million SNPs to find correlations with urine albumin levels.
  • * Six key genetic loci were identified, including FCRL3 and PIEZO2, which may influence kidney health and the development of albuminuria in the study group.
View Article and Find Full Text PDF

Background: Endometriosis is a complex gynaecological disorder that contributes to infertility, dysmenorrhea, dyspareunia, and other chronic issues. It is a multifactorial disease involving genetic, hormonal, immunological and environmental components. Endometriosis's pathogenesis remains unclear.

View Article and Find Full Text PDF

Multiple sclerosis is a complex autoimmune disease, and several therapies for multiple sclerosis have been developed and widely used. However, existing medications for multiple sclerosis were far from satisfactory due to their failure to suppress relapses and alleviate disease progression. Novel drug targets for multiple sclerosis prevention are still needed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!